Mission Pharmacal subsidiary ProSolus Inc. said this week that it expanded its manufacturing capabilities and commercialization efforts for transdermal drug delivery technologies.
The Miami-based company, which develops and manufactures transdermal and trans-mucosal drug delivery products, installed a 2nd transdermal production facility in Boerne, Texas. The new location has a larger production line than the Miami site, according to ProSolus, and the 2 sites have a combined annual capacity of more than 100 million patches.
Get the full story at our sister site, Drug Delivery Business News.